> The MemorEM device is being developed by NeuroEM Therapeutics, and we should point out that two of the authors behind the new study founded the company – so there is some vested commercial interest here.

Nevertheless, the results seem promising in spite of the ridiculously small number of participants, and if other researchers are able to replicate them - that is, if the original study has enough details to build a device with identical EM function - and confirm the results, especially the lack of side-effects claimed by the team, this could be great news to all of us.